Can a heart Pump's data predict who will recover?
NCT ID NCT07619144
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at data from 100 adults with cardiogenic shock who received an Impella 5.5 heart pump. Researchers aim to build a tool that uses pump signals to predict whether a patient's own heart will recover. The goal is to improve decision-making and reduce complications like bleeding or organ failure.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Impella 5.5 micro-axial flow pump (a temporary heart pump device)
- What this could lead to
- If successful, this could lead to a tool that helps doctors predict which patients will recover their own heart function, potentially reducing deaths and complications.
- What could go wrong
- This is a small, early-stage observational study, not a treatment trial. The tool may not prove accurate enough for real-world use, and results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical University of Vienna
RECRUITINGVienna, Austria
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a temporary heart pump save more lives in cardiogenic shock?
- Could starting dialysis sooner save more hearts?
- A tiny probe into the heart's hidden reserve could forecast who needs a transplant
- Can a tiny heart pump Fine-Tune support for failing hearts?
- Could a key hormone be missing in septic shock?
- Heart rate drug may speed recovery from shock after heart attack